Sichuan Kelun Pharmaceutical Hits Day High with Strong 3.21% Surge

Sichuan Kelun Pharmaceutical Co., Ltd. has experienced a notable uptick in its stock performance, gaining 3.21% on July 10, 2026. The stock reached an intraday high of CNY 45.65, reflecting a significant moment in its trading activity. Despite this daily gain, the company has faced challenges over the past week, with a decline of 8.15%. In terms of longer-term performance, Sichuan Kelun has shown resilience, with a remarkable 50.15% increase year-to-date and a substantial 181.06% rise over the past decade. The company's market capitalization stands at CNY 39,696 million, categorizing it as a large-cap entity within the pharmaceuticals and biotechnology sector. Key financial metrics reveal a P/E ratio of 24.00 and a dividend yield of 3.62%. However, the company has reported negative results for the last six consecutive quarters, with a net profit decline of 32.93% and a return on capital employed (ROCE) at a low of 6.58%. These figures highlight the complexities surrounding Sichuan Kelun's current market position amidst its recent stock activity.